OUR CLINICAL TRIALS

  • Reset


A Phase 2 Clinical Trial of multi-agent Chemotherapy or letrozole plus Ribociclib (LEE011) as neoadjuvant Leer mas
A phase 3, multicenter, randomized, open-label, active-controlled study of trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine Leer mas
DOLAF- An international multicenter phase II trial of Durvalumab (MEDI4736) plus OLAparib plus Fulvestrant in Leer mas
European cooperative study of primary systemic therapy in women with operable breast cancer and T Leer mas
ELacestrant In Preoperative SEtting, a window of opportunity study Leer mas
A randomised phase III trial of adjuvant radiation therapy versus observation following breast conserving surgery Leer mas
A phase II randomized, double-blind, study of ipatasertib (GDC-0068), an Akt inhibitor, in combination with Leer mas
A Phase III, multicenter, open-label study of ribociclib vs. palbociclib in patients with advanced hormone Leer mas
Translational Study Of Tumor Samples From DS8201- A-U301 and DS8201-A-U302 Trials Leer mas

COLLABORATE